Literature DB >> 25688403

Does everyone develop covert cancer?

Mel Greaves1.   

Abstract

Around one in three individuals, if they live long enough, will have a confirmed clinical diagnosis of overt cancer, and there is increasing evidence that many of us — I contend all of us — develop covert cancer.

Entities:  

Mesh：

Year:  2014        PMID： 25688403     DOI： 10.1038/nrc3703

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN： 1474-175X            Impact factor:   60.716


  10 in total

1.  Sun-induced nonsynonymous p53 mutations are extensively accumulated and tolerated in normal appearing human skin.

Authors:  Patrik L Ståhl; Henrik Stranneheim; Anna Asplund; Lisa Berglund; Fredrik Pontén; Joakim Lundeberg
Journal:  J Invest Dermatol       Date:  2010-10-14       Impact factor: 8.551

2.  Overdiagnosis and overtreatment in cancer: an opportunity for improvement.

Authors:  Laura J Esserman; Ian M Thompson; Brian Reid
Journal:  JAMA       Date:  2013-08-28       Impact factor: 56.272

3.  The origin and evolution of mutations in acute myeloid leukemia.

Authors:  John S Welch; Timothy J Ley; Daniel C Link; Christopher A Miller; David E Larson; Daniel C Koboldt; Lukas D Wartman; Tamara L Lamprecht; Fulu Liu; Jun Xia; Cyriac Kandoth; Robert S Fulton; Michael D McLellan; David J Dooling; John W Wallis; Ken Chen; Christopher C Harris; Heather K Schmidt; Joelle M Kalicki-Veizer; Charles Lu; Qunyuan Zhang; Ling Lin; Michelle D O'Laughlin; Joshua F McMichael; Kim D Delehaunty; Lucinda A Fulton; Vincent J Magrini; Sean D McGrath; Ryan T Demeter; Tammi L Vickery; Jasreet Hundal; Lisa L Cook; Gary W Swift; Jerry P Reed; Patricia A Alldredge; Todd N Wylie; Jason R Walker; Mark A Watson; Sharon E Heath; William D Shannon; Nobish Varghese; Rakesh Nagarajan; Jacqueline E Payton; Jack D Baty; Shashikant Kulkarni; Jeffery M Klco; Michael H Tomasson; Peter Westervelt; Matthew J Walter; Timothy A Graubert; John F DiPersio; Li Ding; Elaine R Mardis; Richard K Wilson
Journal:  Cell       Date:  2012-07-20       Impact factor: 41.582

4.  Genetic clonal diversity predicts progression to esophageal adenocarcinoma.

Authors:  Carlo C Maley; Patricia C Galipeau; Jennifer C Finley; V Jon Wongsurawat; Xiaohong Li; Carissa A Sanchez; Thomas G Paulson; Patricia L Blount; Rosa-Ana Risques; Peter S Rabinovitch; Brian J Reid
Journal:  Nat Genet       Date:  2006-03-26       Impact factor: 38.330

5.  Using autopsy series to estimate the disease "reservoir" for ductal carcinoma in situ of the breast: how much more breast cancer can we find?

Authors:  H G Welch; W C Black
Journal:  Ann Intern Med       Date:  1997-12-01       Impact factor: 25.391

Review 6.  Darwinian medicine: a case for cancer.

Authors:  Mel Greaves
Journal:  Nat Rev Cancer       Date:  2007-02-15       Impact factor: 60.716

Review 7.  Why don't we get more cancer? A proposed role of the microenvironment in restraining cancer progression.

Authors:  Mina J Bissell; William C Hines
Journal:  Nat Med       Date:  2011-03       Impact factor: 53.440

8.  Chromosome translocations and covert leukemic clones are generated during normal fetal development.

Authors:  Hiroshi Mori; Susan M Colman; Zhijian Xiao; Anthony M Ford; Lyn E Healy; Craig Donaldson; Jill M Hows; Cristina Navarrete; Mel Greaves
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-04       Impact factor: 11.205

9.  The frequency of carcinoma and intraepithelial neoplasia of the prostate in young male patients.

Authors:  W A Sakr; G P Haas; B F Cassin; J E Pontes; J D Crissman
Journal:  J Urol       Date:  1993-08       Impact factor: 7.450

10.  NSAIDs modulate clonal evolution in Barrett's esophagus.

Authors:  Rumen L Kostadinov; Mary K Kuhner; Xiaohong Li; Carissa A Sanchez; Patricia C Galipeau; Thomas G Paulson; Cassandra L Sather; Amitabh Srivastava; Robert D Odze; Patricia L Blount; Thomas L Vaughan; Brian J Reid; Carlo C Maley
Journal:  PLoS Genet       Date:  2013-06-13       Impact factor: 5.917
  10 in total
  15 in total

1.  Perspective: Neuroregenerative Nutrition.

Authors:  Dennis A Steindler; Brent A Reynolds
Journal:  Adv Nutr       Date:  2017-07-14       Impact factor: 8.701

Review 2.  Mutations, Cancer and the Telomere Length Paradox.

Authors:  Abraham Aviv; James J Anderson; Jerry W Shay
Journal:  Trends Cancer       Date:  2017-03-27

Review 3.  Leukaemia 'firsts' in cancer research and treatment.

Authors:  Mel Greaves
Journal:  Nat Rev Cancer       Date:  2016-03       Impact factor: 60.716

Review 4.  Genetic Insights in Barrett's Esophagus and Esophageal Adenocarcinoma.

Authors:  Brian J Reid; Thomas G Paulson; Xiaohong Li
Journal:  Gastroenterology       Date:  2015-07-21       Impact factor: 22.682

Review 5.  Mesothelioma: Scientific clues for prevention, diagnosis, and therapy.

Authors:  Michele Carbone; Prasad S Adusumilli; H Richard Alexander; Paul Baas; Fabrizio Bardelli; Angela Bononi; Raphael Bueno; Emanuela Felley-Bosco; Francoise Galateau-Salle; David Jablons; Aaron S Mansfield; Michael Minaai; Marc de Perrot; Patricia Pesavento; Valerie Rusch; David T Severson; Emanuela Taioli; Anne Tsao; Gavitt Woodard; Haining Yang; Marjorie G Zauderer; Harvey I Pass
Journal:  CA Cancer J Clin       Date:  2019-07-08       Impact factor: 508.702

Review 6.  Evolution of Premalignant Disease.

Authors:  Kit Curtius; Nicholas A Wright; Trevor A Graham
Journal:  Cold Spring Harb Perspect Med       Date:  2017-12-01       Impact factor: 6.915

Review 7.  An evolutionary perspective on field cancerization.

Authors:  Kit Curtius; Nicholas A Wright; Trevor A Graham
Journal:  Nat Rev Cancer       Date:  2017-12-08       Impact factor: 60.716

Review 8.  Evolutionary determinants of cancer.

Authors:  Mel Greaves
Journal:  Cancer Discov       Date:  2015-07-20       Impact factor: 39.397

9.  Dynamics of preventive vs post-diagnostic cancer control using low-impact measures.

Authors:  Andrei R Akhmetzhanov; Michael E Hochberg
Journal:  Elife       Date:  2015-06-25       Impact factor: 8.140

Review 10.  Prevalence of incidental prostate cancer: A systematic review of autopsy studies.

Authors:  Katy J L Bell; Chris Del Mar; Gordon Wright; James Dickinson; Paul Glasziou
Journal:  Int J Cancer       Date:  2015-04-21       Impact factor: 7.396
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.